Sindrome di Muir–Torre (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sindrome di Muir–Torre" in Italian language version.

refsWebsite

Global rank Italian rank

4^th place

9^th place

2^nd place

7^th place

799^th place

22^nd place

6^th place

8^th place

1nbn-resolving.de

3,251^st place

low place

archive.org

James, William D. e Berger, Timothy G., Andrews' Diseases of the Skin: clinical Dermatology, Saunders Elsevier, 2006, ISBN 978-0-7216-2921-6.
Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient's age or other clinical characteristics, in Am J Surg Pathol, vol. 33, n. 6, 2009, pp. 934-44, DOI:10.1097/PAS.0b013e318199edca, PMID 19342947.
Lynch HT, Fussaro RM, Roberts L, Muir–Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome, in Br J Dermatol, vol. 113, n. 3, 1985, pp. 295-301, DOI:10.1111/j.1365-2133.1985.tb02081.x, PMID 4063166.

doi.org

dx.doi.org

Association of sebaceous gland tumors and internal malignancy: The Muir–Torre syndrome, in The American Journal of Medicine, vol. 90, n. 5, May 1991, pp. 606-13, DOI:10.1016/S0002-9343(05)80013-0, PMID 2029018.
Roberts ME, Riegert-Johnson DL, Thomas BC, A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir–Torre variant of Lynch syndrome, in Genetics in Medicine, vol. 16, n. 9, 2014, pp. 711-16, DOI:10.1038/gim.2014.19, PMID 24603434.
Roberts ME, Riegert-Johnson DL, Thomas BC, Screening for Muir–Torre syndrome using mismatch repair protein immunohisochemistry of sebaceous neoplasms, in J Genet Counsel, vol. 22, n. 3, 2013, pp. 393-405, DOI:10.1007/s10897-012-9552-4, PMID 23212176.
Akhtar S, Oza KK, Khan SA, Muir–Torre syndrome: a case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature, in J Am Acad Dermatol, vol. 41, n. 5, 1999, pp. 681-6, DOI:10.1016/s0190-9622(99)70001-0, PMID 10534628.
Simultaneous Muir–Torre and Turcot's syndrome: A case report and review of the literature, in Surg Neurol Int, vol. 4, n. 52, April 2013, p. 52, DOI:10.4103/2152-7806.110512, PMID 23646262.
Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient's age or other clinical characteristics, in Am J Surg Pathol, vol. 33, n. 6, 2009, pp. 934-44, DOI:10.1097/PAS.0b013e318199edca, PMID 19342947.
Muir–Torre Syndrome – Treatment with Isotretinoin and Interferon Alpha-2a Can Prevent Tumour Development, in Dermatology, vol. 200, n. 4, March 2000, pp. 331-3, DOI:10.1159/000018399, PMID 10894967.
Oral isotretinoin therapy for familial Muir–Torre syndrome, in J Am Acad Dermatol, vol. 12, n. 3, March 1985, pp. 475-80, DOI:10.1016/S0190-9622(85)70066-7, PMID 3857234.
Ponti G, Pnz de Leon M, Muir–Torre syndrome, in Lancet Oncol, vol. 6, n. 12, 2005, pp. 980-87, DOI:10.1016/S1470-2045(05)70465-4, PMID 16321766.
The Frequency of Muir–Torre Syndrome Among Lynch Syndrome Families, in Oxford Journal, vol. 100, n. 4, February 2008, pp. 277-81, DOI:10.1093/jnci/djm291, PMID 18270343.
Value of MLH1 and MSH2 mutations in the appearance of Muir–Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas. |, in J Invest Dermatol, vol. 126, n. 10, October 2006, pp. 2302-7, DOI:10.1038/sj.jid.5700475, PMID 16826164.
Muir–Torre syndrome: a case report and review of the literature, in Turk J Gastroenterol, vol. 23, n. 4, August 2012, pp. 394-8, DOI:10.4318/tjg.2012.0411, PMID 22965514.
Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face, in Br J Surg, vol. 54, n. 3, March 1967, pp. 191-5, DOI:10.1002/bjs.1800540309, PMID 6020987.
Torre D, Multiple sebaceous tumors, in Arch Dermatol, vol. 98, n. 5, November 1968, pp. 549-51, DOI:10.1001/archderm.98.5.549, PMID 5684233.
Lynch HT, Fussaro RM, Roberts L, Muir–Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome, in Br J Dermatol, vol. 113, n. 3, 1985, pp. 295-301, DOI:10.1111/j.1365-2133.1985.tb02081.x, PMID 4063166.

nbn-resolving.de

Muir–Torre Syndrome – Treatment with Isotretinoin and Interferon Alpha-2a Can Prevent Tumour Development, in Dermatology, vol. 200, n. 4, March 2000, pp. 331-3, DOI:10.1159/000018399, PMID 10894967.

nih.gov

ncbi.nlm.nih.gov

Association of sebaceous gland tumors and internal malignancy: The Muir–Torre syndrome, in The American Journal of Medicine, vol. 90, n. 5, May 1991, pp. 606-13, DOI:10.1016/S0002-9343(05)80013-0, PMID 2029018.
Roberts ME, Riegert-Johnson DL, Thomas BC, A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir–Torre variant of Lynch syndrome, in Genetics in Medicine, vol. 16, n. 9, 2014, pp. 711-16, DOI:10.1038/gim.2014.19, PMID 24603434.
Roberts ME, Riegert-Johnson DL, Thomas BC, Screening for Muir–Torre syndrome using mismatch repair protein immunohisochemistry of sebaceous neoplasms, in J Genet Counsel, vol. 22, n. 3, 2013, pp. 393-405, DOI:10.1007/s10897-012-9552-4, PMID 23212176.
Akhtar S, Oza KK, Khan SA, Muir–Torre syndrome: a case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature, in J Am Acad Dermatol, vol. 41, n. 5, 1999, pp. 681-6, DOI:10.1016/s0190-9622(99)70001-0, PMID 10534628.
Muir–Torre Syndrome / Turcot Syndrome overlap? A patient with sebaceous carcinoma, colon cancer, and a malignant astrocytoma, in Dermatology Online Journal, vol. 18, n. 5, May 2012, p. 3, PMID 22630573.
Simultaneous Muir–Torre and Turcot's syndrome: A case report and review of the literature, in Surg Neurol Int, vol. 4, n. 52, April 2013, p. 52, DOI:10.4103/2152-7806.110512, PMID 23646262.
Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient's age or other clinical characteristics, in Am J Surg Pathol, vol. 33, n. 6, 2009, pp. 934-44, DOI:10.1097/PAS.0b013e318199edca, PMID 19342947.
Muir–Torre Syndrome – Treatment with Isotretinoin and Interferon Alpha-2a Can Prevent Tumour Development, in Dermatology, vol. 200, n. 4, March 2000, pp. 331-3, DOI:10.1159/000018399, PMID 10894967.
Oral isotretinoin therapy for familial Muir–Torre syndrome, in J Am Acad Dermatol, vol. 12, n. 3, March 1985, pp. 475-80, DOI:10.1016/S0190-9622(85)70066-7, PMID 3857234.
Ponti G, Pnz de Leon M, Muir–Torre syndrome, in Lancet Oncol, vol. 6, n. 12, 2005, pp. 980-87, DOI:10.1016/S1470-2045(05)70465-4, PMID 16321766.
The Frequency of Muir–Torre Syndrome Among Lynch Syndrome Families, in Oxford Journal, vol. 100, n. 4, February 2008, pp. 277-81, DOI:10.1093/jnci/djm291, PMID 18270343.
Value of MLH1 and MSH2 mutations in the appearance of Muir–Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas. |, in J Invest Dermatol, vol. 126, n. 10, October 2006, pp. 2302-7, DOI:10.1038/sj.jid.5700475, PMID 16826164.
Muir–Torre syndrome: a case report and review of the literature, in Turk J Gastroenterol, vol. 23, n. 4, August 2012, pp. 394-8, DOI:10.4318/tjg.2012.0411, PMID 22965514.
Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face, in Br J Surg, vol. 54, n. 3, March 1967, pp. 191-5, DOI:10.1002/bjs.1800540309, PMID 6020987.
Torre D, Multiple sebaceous tumors, in Arch Dermatol, vol. 98, n. 5, November 1968, pp. 549-51, DOI:10.1001/archderm.98.5.549, PMID 5684233.
Lynch HT, Fussaro RM, Roberts L, Muir–Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome, in Br J Dermatol, vol. 113, n. 3, 1985, pp. 295-301, DOI:10.1111/j.1365-2133.1985.tb02081.x, PMID 4063166.

oadoi.org

Association of sebaceous gland tumors and internal malignancy: The Muir–Torre syndrome, in The American Journal of Medicine, vol. 90, n. 5, May 1991, pp. 606-13, DOI:10.1016/S0002-9343(05)80013-0, PMID 2029018.
Roberts ME, Riegert-Johnson DL, Thomas BC, A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir–Torre variant of Lynch syndrome, in Genetics in Medicine, vol. 16, n. 9, 2014, pp. 711-16, DOI:10.1038/gim.2014.19, PMID 24603434.
Roberts ME, Riegert-Johnson DL, Thomas BC, Screening for Muir–Torre syndrome using mismatch repair protein immunohisochemistry of sebaceous neoplasms, in J Genet Counsel, vol. 22, n. 3, 2013, pp. 393-405, DOI:10.1007/s10897-012-9552-4, PMID 23212176.
Akhtar S, Oza KK, Khan SA, Muir–Torre syndrome: a case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature, in J Am Acad Dermatol, vol. 41, n. 5, 1999, pp. 681-6, DOI:10.1016/s0190-9622(99)70001-0, PMID 10534628.
Simultaneous Muir–Torre and Turcot's syndrome: A case report and review of the literature, in Surg Neurol Int, vol. 4, n. 52, April 2013, p. 52, DOI:10.4103/2152-7806.110512, PMID 23646262.
Oral isotretinoin therapy for familial Muir–Torre syndrome, in J Am Acad Dermatol, vol. 12, n. 3, March 1985, pp. 475-80, DOI:10.1016/S0190-9622(85)70066-7, PMID 3857234.
Ponti G, Pnz de Leon M, Muir–Torre syndrome, in Lancet Oncol, vol. 6, n. 12, 2005, pp. 980-87, DOI:10.1016/S1470-2045(05)70465-4, PMID 16321766.
The Frequency of Muir–Torre Syndrome Among Lynch Syndrome Families, in Oxford Journal, vol. 100, n. 4, February 2008, pp. 277-81, DOI:10.1093/jnci/djm291, PMID 18270343.
Value of MLH1 and MSH2 mutations in the appearance of Muir–Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas. |, in J Invest Dermatol, vol. 126, n. 10, October 2006, pp. 2302-7, DOI:10.1038/sj.jid.5700475, PMID 16826164.
Muir–Torre syndrome: a case report and review of the literature, in Turk J Gastroenterol, vol. 23, n. 4, August 2012, pp. 394-8, DOI:10.4318/tjg.2012.0411, PMID 22965514.
Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face, in Br J Surg, vol. 54, n. 3, March 1967, pp. 191-5, DOI:10.1002/bjs.1800540309, PMID 6020987.
Torre D, Multiple sebaceous tumors, in Arch Dermatol, vol. 98, n. 5, November 1968, pp. 549-51, DOI:10.1001/archderm.98.5.549, PMID 5684233.